LRRK2 G2019S in the North African population: A review

European Neurology

Volumn 63, Issue 6, 2010, Pages 321-325

  Benamer, Hani T S ^a   De Silva, Rajith ^b  

^a NEW CROSS HOSPITAL   (United Kingdom)

^b QUEEN S HOSPITAL   (United Kingdom)

Author keywords

LRRK2; North Africa; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; GLYCINE; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SERINE;

GENE FREQUENCY; GENE MUTATION; HUMAN; NORTH AFRICA; PARKINSON DISEASE; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; AFRICA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; POPULATION GROUP;

AFRICA, NORTHERN; GENETIC PREDISPOSITION TO DISEASE; GLYCINE; HUMANS; PARKINSON DISEASE; POPULATION GROUPS; PROTEIN-SERINE-THREONINE KINASES; SERINE;

EID: 77951057074     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000279653     Document Type: Review

References (18)

1. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, et al: Phenotype, genotype, and worldwide genetic penetrance of LRRK2 -associated Parkinson's disease: a case-control study. Lancet Neurol 2008; 7: 583-590.
2. Brett M, Fentress E: The Berbers. Oxford, Blackwell, 1997.
3. Lesage S, Durr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A: LRRK2 G2019S as a cause o f Parkinson's disease in North African Arabs. N Engl J Med 2006; 354: 422-423.
4. Lesage S, Ibanez P, Lohmann E, Pollak P, Tison F, Tazir M, e t al: G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol 2005; 58: 784-787.
5. Ishihara L, Gibson RA, Warren L, Amouri R, Lyons K, Wielinski C, et al: Screening for LRRK2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord 2007; 22: 55-61.
6. Lesage S, Belarbi S, Troiano A, Condroyer C, Hecham N, Pollak P, et al: Is the common LRRK2 G2019S mutatio n related to dyskinesias in North African Parkinson disease? Neurology 2008; 71: 1550-1552.
7. Hulihan MM, Ishihara-Paul L, Kachergus J, Warren L, Amouri R, Elango R: LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study. Lancet Neurol 2008; 7: 591-594.
8. Healy DG, Wood NW, Schapira AH: Test for LRRK2 mutations in patients with Parkinson's disease. Pract Neurol 2008; 8: 381-385.
9. Nishioka KMP, Kefi MM, Jasinska-Myga BMP, Wider CM, Vilarino-Guell CP, Ross OP: A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson disease. J Neurol Neurosurg Psychiatry 2010;81:391-395.
10. Change N, Mercier G, Lucotte G: Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects. Genet Test 2008; 12: 333-339.
11. Lesage S, Leutenegger AL, Ibanez P, Janin S, Lohmann E, Durr A, et al: LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 2005; 77: 330-332.
12. Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, et al: LRRK2 G2019S i n families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 2006; 79: 752-758.
13. Warren L, Gibson R, Ishihara L, Elango R, Xue Z, Akkari A, et al: A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. Parkinsonism Relat Disord 2008; 14: 77-80.
14. Chaabani H, Cox DW: Genetic characterization and origin of Tunisian Berbers. Hum Hered 1988; 38: 308-316.
15. Chaabani H, Sanchez-Mazas A, Sallami SF: Genetic differentiation of Yemeni people according to rhesus and Gm polymorphisms. Ann Genet 2000; 43: 155-162.
16. Abdennaji GB, Loueslati BY, Buhler S, Hmida S, Ennafaa H, Khodjet-Elkhil H, et al: HLA class II genetic diversity in southern Tunisia and the Mediterranean area. Int J Immunogenet 2006; 33: 93-103.
17. Ennafaa H, Amor MB, Yacoubi-Loueslati B, Khodjet el-khil H, et al: Alu polymorphisms in Jerba Island population (Tunisia): comparative study in Arab and Berber groups. Ann Hum Biol 2006; 33: 634-640.
18. Farrer MJ, Gibson R, Hentati F: The ancestry of LRRK2 Gly2019Ser parkinsonism (authors' reply). Lancet Neurol 2009; 7: 770.